The US is losing ground to the European Union in cannabis sales

476 0

Cannabis sales in the EU are much higher than in the US

While it is true that the US cannabis industry is growing at an exponential level never before imagined, the rest of the world is also doing its own thing with respect to its market, and the EU is not lagging behind at all, nor does it plan to do so. At the moment, the race in both regions seems to be quite tight, but the EU is stepping on the gas and could soon start to take the lead.

It is no secret that the global cannabis market is experiencing astronomical growth, and this is mainly due to factors that include increased demand for legal marijuana by millions of consumers, new and innovative technologies, relaxed regulations, a change in stereotypes, and an urgent need for options to treat the symptoms of many pathologies.

While the US market is quite hot and attractive to investors, they should now also turn their eyes to the right side of the map and consider the EU cannabis industry. While there is still some way to go for the US to receive federal approval, Europe is already fine-tuning some of the details to make widespread legalization a fact of life.

The European market has within its capabilities the ability to outperform the US market for several reasons, mainly due to efficiency and innovation, a regulatory framework that rewards quality, and not to mention that there is no room to be dealing with regulatory headaches on a state-by-state basis. It is true that the US has begun to see a trend of decriminalization and legalization at the state level in the last decade, but this has simply led to a regulatory patchwork, indicating that a federal cannabis bureaucracy could hinder growth and prosperity. All of that creates inconvenience, which means there is still an uncomfortable gray area.

On the other hand, most of Europe treats cannabis cultivation like the manufacture of any other medicine, and operators must just follow the requirements of a pharmaceutical factory handling narcotics. There are not as many hurdles for the cannabis industry in this region, and while perhaps still in its infancy, it shows much more promise and standardization than the current regulatory framework in the US.